MENU
SNGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Soligenix (SNGX) Ownership - Who owns Soligenix?
Soligenix Inc is a late-stage biopharmaceutical company based in the United States... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
4.34M
P/E Ratio
N/A
Total Cash
7.3M
Projected Growth
N/A
Total Debt
79.13K
Revenue
-117.03K
Risk (Beta)
2.70
Dividend Yield
N/A
Total Cash/Share
2.24
Total Debt/Equity
N/A
Revenue/Share
-0.05 USD as % of share price
Fundamentals
SNGX
Capitalization
4.34M
P/E Ratio
N/A
Risk (Beta)
2.70
Dividend Yield
N/A
Total Cash
7.3M
Total Cash/Share
2.24
Total Debt
79.1K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
-0.05%
Revenue
-117.03K
ROE
N/A
Book Value
3.61M
P/B Ratio
1.23
Cash Flow
N/A
Earnings
-3.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.18K
Current Ratio
1.85
Current Revenue Per Employee
7801.93
Dividends Per Share - Security
N/A
EBITDA
-10.78M
Float
N/A
Float - Current
N/A
Gross Income Margin
0.00
Revenue To Assets
-121.33
Shares Held By Institutions
354K
Shares Outstanding - Current
3.26M
Total Liabilities
4.13M
Total Volume MTD
N/A
Value
1
Gain YTD
-49.536
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a manufacturer of biodefense vaccines and oral therapeutic products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
29 Emmons Drive
Phone
+1 609 538-8200
Employees
15
Web
https://www.soligenix.com